Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects
出版年份 2022 全文链接
标题
Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2022-01-04
DOI
10.1093/schbul/sbab153
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neurobiology of novelty seeking
- (2021) Zahra Z. Farahbakhsh et al. SCIENCE
- Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress
- (2020) Shirley Alteba et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice
- (2019) Marta Kruk-Slomka et al. MOLECULAR NEUROBIOLOGY
- Endocannabinoid Signaling Mediates Local Dendritic Coordination between Excitatory and Inhibitory Synapses
- (2019) Hai Yin Hu et al. Cell Reports
- Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
- (2018) Sharon Fidelman et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective
- (2018) Julia M. Sheffield et al. NEUROPSYCHOLOGY REVIEW
- Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses
- (2018) Tina Zimmermann et al. NEUROPSYCHOPHARMACOLOGY
- The current conceptualization of negative symptoms in schizophrenia
- (2017) Stephen R. Marder et al. World Psychiatry
- Sex differences in hippocampal response to endocannabinoids after exposure to severe stress
- (2016) Tomer Mizrachi Zer-Aviv et al. HIPPOCAMPUS
- Orchestrated activation of mGluR5 and CB1 promotes neuroprotection
- (2016) Edleusa M. L. Batista et al. Molecular Brain
- Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus
- (2015) N. Tabatadze et al. JOURNAL OF NEUROSCIENCE
- Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders
- (2015) S A Barnes et al. MOLECULAR PSYCHIATRY
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia
- (2014) Lakshmi Rajagopal et al. CURRENT PHARMACEUTICAL DESIGN
- Prereproductive Stress to Female Rats Alters Corticotropin Releasing Factor Type 1 Expression in Ova and Behavior and Brain Corticotropin Releasing Factor Type 1 Expression in Offspring
- (2013) Hiba Zaidan et al. BIOLOGICAL PSYCHIATRY
- Phencyclidine-Induced Social Withdrawal Results from Deficient Stimulation of Cannabinoid CB1 Receptors: Implications for Schizophrenia
- (2013) Alexandre Seillier et al. NEUROPSYCHOPHARMACOLOGY
- Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats
- (2012) V. Trezza et al. JOURNAL OF NEUROSCIENCE
- Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system?
- (2012) Rebecca M. Craft et al. LIFE SCIENCES
- Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
- (2012) Christine Vogel et al. NATURE REVIEWS GENETICS
- Evidence for involvement of nitric oxide and GABAB receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex
- (2012) Nicole L. Roenker et al. NEUROPHARMACOLOGY
- Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
- (2011) David A. Lewis et al. TRENDS IN NEUROSCIENCES
- Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
- (2010) MS García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats
- (2010) Ji-Tao Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
- (2010) Joanna C. Neill et al. PHARMACOLOGY & THERAPEUTICS
- Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
- (2010) Caline S. Karam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat
- (2009) Claire E. McKibben et al. BEHAVIOURAL BRAIN RESEARCH
- Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats
- (2009) Ilsun M. White et al. BRAIN RESEARCH
- Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats
- (2009) Agnieszka Nikiforuk et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Role of cannabis and endocannabinoids in the genesis of schizophrenia
- (2009) Emilio Fernandez-Espejo et al. PSYCHOPHARMACOLOGY
- Models of schizophrenia in humans and animals based on inhibition of NMDA receptors
- (2008) Věra Bubeníková-Valešová et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia
- (2008) G. Gonzalez-Burgos et al. SCHIZOPHRENIA BULLETIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started